An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota.
10.1016/S1875-5364(19)30003-2
- Author:
Shan-Shan SUN
1
,
2
;
Kai WANG
3
,
4
;
Ke MA
3
,
4
;
Li BAO
3
,
4
;
Hong-Wei LIU
3
,
5
Author Information
1. School of Life Sciences, University of Science and Technology of China, Hefei 230026, China
2. State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
3. State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
4. University of Chinese Academy of Sciences, Beijing, 100049, China.
5. University of Chinese Academy of Sciences, Beijing, 100049, China. Electronic address: liuhw@im.ac.cn.
- Publication Type:Journal Article
- Keywords:
Gut microbiota;
Metabolic syndrome;
Poria cocos;
Prebiotics;
Water insoluble polysaccharide
- MeSH:
Animals;
Bacteria;
classification;
genetics;
isolation & purification;
metabolism;
Butyrates;
metabolism;
Fatty Liver;
drug therapy;
Fungal Polysaccharides;
chemistry;
pharmacology;
therapeutic use;
Gastrointestinal Microbiome;
drug effects;
genetics;
Hyperglycemia;
drug therapy;
Hyperlipidemias;
drug therapy;
Intestines;
drug effects;
microbiology;
Male;
Metabolic Syndrome;
drug therapy;
Mice;
Mice, Obese;
Prebiotics;
Wolfiporia;
chemistry
- From:
Chinese Journal of Natural Medicines (English Ed.)
2019;17(1):3-14
- CountryChina
- Language:English
-
Abstract:
Metabolic syndrome characterized by obesity, hyperglycemia and liver steatosis is becoming prevalent all over the world. Herein, a water insoluble polysaccharide (WIP) was isolated and identified from the sclerotium of Poria cocos, a widely used Traditional Chinese Medicine. WIP was confirmed to be a (1-3)-β-D-glucan with an average Mw of 4.486 × 10 Da by NMR and SEC-RI-MALLS analyses. Furthermore, oral treatment with WIP from P. cocos significantly improved glucose and lipid metabolism and alleviated hepatic steatosis in ob/ob mice. 16S DNA sequencing analysis of cecum content from WIP-treated mice indicated the increase of butyrate-producing bacteria Lachnospiracea, Clostridium. It was also observed that WIP treatment elevated the level of butyrate in gut, improved the gut mucosal integrity and activated the intestinal PPAR-γ pathway. Fecal transplantation experiments definitely confirmed the causative role of gut microbiota in mediating the benefits of WIP. It is the first report that the water insoluble polysaccharide from the sclerotium of P. cocos modulates gut microbiota to improve hyperglycemia and hyperlipidemia. Thereby, WIP from P. cocos, as a prebiotic, has the potential for the prevention or cure of metabolic diseases and may elucidate new mechanism for the efficacies of this traditional herbal medicine on the regulation of lipid and glucose metabolism.
